WELCOME TO SEATTLE for the
47th Annual Meeting
March 16-20, 2008
Please attend the
CVSS Luncheon meeting March 19, Wednesday 12:00 Noon to 1:30 PM, Sheraton Seattle Hotel, Willow Room, no reservations required.
CVSS-Sponsored Topics 2007
Rodent Imaging Overview for the Toxicologist- Chairperson(s): Kathleen
Gabrielson, Johns Hopkins University, Baltimore, MD and Robert Maronpot, National
Institute of Environmental Health Sciences, Research
Triangle Park, NC
Endorsed by:
Comparative and Veterinary Specialty Section*
Drug Discovery Specialty Section
Mechanisms Specialty Section
Toxicologic & Exploratory Pathology Specialty Section
Toxicologic & Exploratory Pathology Specialty SectionIn the
last decade, in vivo imaging methods have become established tools in basic
science research.
This course is designed to provide a general overview of imaging modalities
utilized in basic science with applications to drug discovery and toxicological
research. This review will focus on five imaging modalities including: MR,
PET, SPECT, optical and ultrasound. Each speaker will give a basic overview
of the modality and present specific examples relevant to drug discovery
and toxicological research. In this review, several applications of MRI, Magnetic
Resonance Spectroscopy and Electron Paramagnetic Resonance in oncology, cardiovascular
disease and morphological phenotyping during toxicological studies will be
described. PET and SPECT imaging of radioactively labeled compounds will
be
reviewed in the setting of drug discovery and toxicological research. The
application of the multi-modality imaging scanners will also be discussed.
These multi-modalities
studies provide comprehensive evaluation that enables the toxicologist to
study structure, function, in tandem with distribution and metabolism of radioactively
labeled drugs. PET imaging of gene expression during pharmacology studies
will
be reviewed. Optical imaging will be reviewed in the context of imaging gene
expression in transgenic mice engineered with gene promoters from enzymes
(CYP1A2 or CYP3A4) driving luciferase expression. Signal transduction pathway
discovery
in toxicological research will be discussed using optical imaging in transgenic
mice with a Smad-responsive luciferase reporter. Ultrasound imaging will
be overviewed using applications of toxicity and drug discovery in cardiovascular
and cancer mouse models. Following completion of this workshop, attendees
should
have basic understanding of the various imaging modalities and applications
to drug discovery and toxicological research.
Overview: Applicability/Feasibility
of Rodent Imaging for the Toxicologist
Kathleen Gabrielson, Johns Hopkins University, Baltimore, MD
Magnetic Resonance
Imaging
Robert Maronpot, National Institute of Environmental Health Sciences, Research
Triangle Park, NC
Positron Emission Tomography and Single Photon Emission
Computed Tomography
Benjamin Tsui, Johns Hopkins University, Baltimore, MD
Optical Imaging
Pamela Contag, Xenogen Corporation, Alameda, CA